TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma January 30, 2009
TCL Archive November issue of Business & Regulatory Report, an additional 8 pages, included in this issue. November 19, 2004
